ENG and neoplasm: In this work, we generated from renal cell carcinoma CSC-derived and tumor-derived endothelial cells expressing the surface glycoprotein CD105 (Endoglin) and tested the effect of TRC105, a CD105 monoclonal antibody, on the angiogenic properties of these tumor endothelial cells (TEC).